T 0429/96 (Serine protease inhibitors/AMGEN) of 31.05.2001
- European Case Law Identifier
- ECLI:EP:BA:2001:T042996.20010531
- Date of decision
- 31 May 2001
- Case number
- T 0429/96
- Petition for review of
- -
- Application number
- 86900423.4
- IPC class
- C07K 7/10
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SERINE PROTEASE INHIBITORS AND METHODS FOR ISOLATION OF SAME
- Applicant name
- Amgen Inc.
- Opponent name
- Teijin Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973
- Keywords
- Admissibility of the grounds of opposition under Article 83 and 56 (yes)
Sufficiency of disclosure (yes)
Novelty (yes)
Inventive steps (yes) - Catchword
- -
- Citing cases
- T 0485/18
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the claims filed during the oral proceedings in the two versions, one for AT and one for the other designated Contracting States, and description pages 4 to 8 as filed during the oral proceedings and pages 3 and 9 to 14 as granted.